3-Chloro-N-cyclopropyl-N-[(4-methoxyphenyl)methyl]benzene-1-sulfonamide

Catalog No. :
ACGXGS842
CAS No. :
1043344-89-3
Molecular Formula :
C17H18ClNO3S
Molecular Weight :
351.86

IUPAC Name:3-chloro-N-cyclopropyl-N-(4-methoxybenzyl)benzenesulfonamide

3-Chloro-N-cyclopropyl-N-[(4-methoxyphenyl)methyl]benzene-1-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$383.00Login to see priceInquiryInquiry
5g95%$1150.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chloro-N-cyclopropyl-N-[(4-methoxyphenyl)methyl]benzene-1-sulfonamide
IUPAC Name3-chloro-N-cyclopropyl-N-(4-methoxybenzyl)benzenesulfonamide
MDL No.MFCD10752176
Molecular FormulaC17H18ClNO3S
Molecular Weight351.86
SMILESCOC1=CC=C(C=C1)CN(S(=O)(C2=CC(Cl)=CC=C2)=O)C3CC3
InChI KeyMXMPEJPGGCHDHD-UHFFFAOYSA-N
SynonymBenzenesulfonamide, 3-chloro-N-cyclopropyl-N-[(4-methoxyphenyl)methyl]-;3-chloro-N-cyclopropyl-N-[(4-methoxyphenyl)methyl]benzene-1-sulfonamide
CAS No.1043344-89-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGXGS842 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBZLT583 route compound structure diagram
    ACBZLT58370894-71-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGXGS842 route product structure diagram
    ACGXGS8421043344-89-3
Inquiry

2. ACGXGS842 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGXGS842 route product structure diagram
    ACGXGS8421043344-89-3
Inquiry

Comments (0)